The first quarter 2008 sales and results were reviewed by Hanspeter Spek, Executive Vice President, Pharmaceutical Operations, Jean-Claude Leroy, Executive Vice President, Finance and Legal and Marc Cluzel, Senior Vice President, Research and Development.
The presentation was followed by a Q&A session.
Recorded audio webcast held on April 30 at 8 a.m (CET)
